Abstracts

MITOCHONDRIAL DYSFUNCTION IN WELL-SUPPRESSED PERINATALLY HIV-INFECTED CHILDREN ON ART

Although abnormalities in mitochondrial (mt) biomarkers are reported in HIV-infected children and/or antiretroviral treatment (ART), mt function in children with sustained viral suppression after initiation of ART in early life has not been described. Here we examined multiple markers of mt function in HIV-infected children on ART. We selected a cross-sectional sample of 120 HIV-infected…

VITAMIN D SUPPLEMENTATION ATTENUATES IMMUNE ACTIVATION IN HIV+ AVIREMIC YOUTH

Heightened immune activation and global immune dysfunction drive HIV disease progression and co-morbidities. Vitamin D has pleiotropic effects on the immune system, but little is known about the long-term effects of supplementation in HIV-infected youth. This is a 24-month randomized, active-control, double-blind trial investigating 3 different monthly vitamin D3 doses [18,000 (standard), 60,000 (moderate) or…

MATERNAL ANTIRETROVIRAL THERAPY IN PREGNANCY AND NEONATE PRETREATMENT VIRAL LOAD

With expansion of effective maternal antiretroviral therapy (ART), rates of new infant HIV infections are low but a large proportion of infected infants are exposed to antiretrovirals before birth. We investigated relationships between maternal ART in pregnancy and pre-treatment (PT) viral load (VL) profiles in intrauterine-infected neonates. Between June 2014-September 2017, 79 neonates with confirmed…

T AND B CELL RESPONSES ASSOCIATE WITH SMALLER HIV RESERVOIR SIZE IN INFANTS AFTER ART

The infant immune system is characterized by reduced HIV-specific immune responses, resulting in an inability to control HIV viremia. We investigated the activation and maturation of T and B cells in HIV+ infants before and after successful antiretroviral therapy (ART). Nine HIV-infected Thai infants were included: 4 virally non-suppressed at baseline, either pre-ART (n=2) or…

EARLY CMV AND EBV ACQUISITION PREDICTS HIV DNA LEVELS IN INFANTS ON SUPPRESSIVE ART

Defining modifiable factors associated with HIV reservoir size may inform novel interventions to enable post-treatment control of HIV infection. HIV-infected infants in Africa often acquire cytomegalovirus (CMV) and Epstein-Barr virus (EBV) within a few weeks of HIV; primary infection with each of these initiates dramatic changes in immune activation and could impact HIV reservoir formation.…